id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-N-2796-0003,FDA,FDA-2022-N-2796,Bristol Myers Products Inc.; Withdrawal of Approval of a New Drug Application for BUFFERIN (Aspirin) Tablets,Notice,Withdrawal,2023-07-21T04:00:00Z,2023,7,2023-07-21T04:00:00Z,,2023-07-21T13:27:39Z,2023-15454,0,0,0900006485cf8e61